Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
4DMedical Ltd ( (AU:4DX) ) has provided an update.
4DMedical Ltd has announced the quotation of new securities on the Australian Securities Exchange (ASX), with a total of 2,327,633 ordinary fully paid shares to be listed. This move is part of the company’s strategy to leverage financial markets for growth and expansion, potentially enhancing its market position and providing additional resources for its operations, which could have significant implications for stakeholders.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, specializing in advanced respiratory imaging solutions. The company focuses on developing innovative products to enhance the diagnosis and treatment of lung conditions, aiming to improve patient outcomes and streamline healthcare processes.
Average Trading Volume: 5,044,779
Technical Sentiment Signal: Buy
Current Market Cap: A$1.15B
See more insights into 4DX stock on TipRanks’ Stock Analysis page.